Comprehensive statistical analysis of predictive markers to immune checkpoint inhibitors in patients with non-small cell lung cancer

被引：0
|
作者：
Hiltbrunner, S. [1 ]
Spohn, M-L. [2 ]
Wechsler, R. [2 ]
Sanoyan, D. Akhoundova [1 ]
Bankel, L. [1 ]
Kasser, S. [1 ]
Bihr, S. [1 ]
Britschgi, C. [1 ]
Maathuis, M. H. [2 ]
Curioni-Fontecedro, A. [1 ]
机构：
[1] Univ Hosp Zurich, Dept Med Oncol & Hematol, Zurich, Switzerland
[2] Swiss Fed Inst Technol, Dept Math, Zurich, Switzerland
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
22P
引用
收藏
页码：S1382 / S1382
页数：1
相关论文
共 50 条
  • [31] Incidence of Cardiotoxicity in Patients Treated for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Carpenter, I. N.
    Brice, K. B.
    Walker, D.
    Dumais, K.
    Alvarez, A. M.
    Cohen, N. S.
    Raez, L. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S629 - S629
  • [32] Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
    Wang, Shuai
    Hao, Jiatao
    Wang, Hao
    Fang, Yong
    Tan, Lijie
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [33] Immune checkpoint inhibitors in therapy of non-small cell lung cancer (a review)
    Kolesnik, O. P.
    Mykhailychenko, V. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (03) : 418 - 425
  • [34] Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
    Zhenbin Qiu
    Zihao Chen
    Chao Zhang
    Wenzhao Zhong
    Experimental Hematology & Oncology, 8
  • [35] Re-administration of immune checkpoint inhibitors for patients with non-small cell lung cancer
    Hakozaki, Taiki
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022,
  • [36] Infectious Complications in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Guo, Matthew Z.
    Balaji, Aanika
    Murray, Joseph C.
    Reuss, Joshua E.
    Steinke, Seema Mehta
    Bennett, Kathleen
    Naidoo, Jarushka
    CLINICAL LUNG CANCER, 2023, 24 (07) : 613 - 620
  • [37] Impact of Gender on Response to Immune Checkpoint Inhibitors in Patients with Non-small Cell Lung Cancer
    Lee, J. C.
    Choi, M. G.
    Ji, W.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S357 - S358
  • [38] Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
    Khatir, Wassila
    Humbert, Olivier
    Benzaquen, Jonathan
    Bontoux, Christophe
    Neels, Jaap
    Berland, Lea
    Rivera, Fabian Andres Gallardo
    Allegra, Maryline
    Salah, Myriam
    Tanga, Virginie
    Bordone, Olivier
    Fayada, Julien
    Lespinet-Fabre, Virginie
    Bohly, Doriane
    Long-Mira, Elodie
    Lassalle, Sandra
    Vouret, Valerie
    Brest, Patrick
    Mograbi, Baharia
    Maniel, Charlotte
    Otto, Josiane
    Boutros, Jacques
    Heeke, Simon
    Hofman, Veronique
    Marquette, Charles-Hugo
    Hofman, Paul
    Ilie, Marius
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (08):
  • [39] Real world prevalence and use of immune checkpoint inhibitors among non-small cell lung cancer patients in a comprehensive cancer center
    Mittal, Garima
    Bates, Benjamin
    Salas, Maribel
    Sundararajan, Meera G.
    Henderson, Mackenzie
    Malhotra, Jyoti
    Chen, Haoqian
    Setoguchi, Soko
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 362 - 362
  • [40] WDR49 mutation as a novel predictive biomarker in patients with non-small cell lung cancer with immune checkpoint inhibitors
    Shi, Zhihui
    Liu, Yaqin
    Zhao, Lele
    Chen, Lin
    Yang, Qidong
    Xiao, Mingzhe
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345